DAIC

SEPTEMBER 11, 2024

million Americans have atrial fibrillation. Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

Journal of the American Heart Association

DECEMBER 24, 2024

Journal of the American Heart Association, Ahead of Print. We compared cardiovascular events between cohorts using causespecific Cox proportional hazards regression.

Kidney Disease 45

Kidney Disease Arrhythmia Myocardial Infarction Atrial Fibrillation 45

Open Heart

JULY 10, 2023

Objective Risk-guided atrial fibrillation (AF) screening may be an opportunity to prevent adverse events in addition to stroke. We compared events rates for new diagnoses of cardio-renal-metabolic diseases and death in individuals identified at higher versus lower-predicted AF risk. years), heart failure (124.7;

Atrial Fibrillation 52

Atrial Fibrillation Myocardial Infarction Kidney Disease Innovation 52

Open Heart

JUNE 1, 2022

Objectives We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE).

Heart Failure 52

Heart Failure Kidney Disease Atrial Fibrillation Hypertension 52

DAIC

DECEMBER 8, 2023

Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).

Atrial Fibrillation 52

Atrial Fibrillation AFIB Stroke Strokes 52

Journal of Cardiovascular Electrophysiology

NOVEMBER 25, 2024

ABSTRACT Introduction Pulmonary vein isolation (PVI) by cryoballoon ablation (CBA) is considered an effective primary strategy for early persistent atrial fibrillation (AF). However, data regarding CBA for long-standing persistent AF (PeAF) are limited. years, 80% men) underwent de novo CBA. During a mean follow-up period of 15.110.9

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Kidney Disease 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 5, 2023

Abstract Introduction Influence of early atrial fibrillation (AF) ablation, particularly cryoballoon ablation (CBA), on clinical outcome during long-term follow-up has not been clarified. The primary outcome was recurrence of atrial tachyarrhythmias (ATs) of ≥30-s after a 3-month blanking period. vs. 31.7%, p  = 0.043).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Kidney Disease 40

Circulation: Heart Failure

MARCH 8, 2024

Circulation: Heart Failure, Ahead of Print. Background:Current prevalence estimates of heart failure (HF) are primarily based on self-report or HF hospitalizations. Overt cardiovascular disease, which ranged from 2.1% (HF) to 13.6% (atrial fibrillation), was less common.

Heart Failure 40

Heart Failure Atherosclerosis Kidney Disease Risk Factors 40

European Journal of Heart Failure

JANUARY 20, 2025

The predictive ability of different risk scores developed and validated to predict the risk of mortality in patients with heart failure in the HELP-HF cohort is reported and compared based on their areas under the curve.

Heart Failure 40

Heart Failure Coronary Artery Disease Myocardial Infarction Kidney Disease 40

Stroke Journal

DECEMBER 8, 2023

BACKGROUND:Limited data exist on the temporal relationship between new-onset atrial fibrillation (AF) and ischemic stroke and its impact on patients’ clinical characteristics and mortality.METHODS:A population-based registry-linkage database includes all patients with new-onset AF in Finland from 2007 to 2018. Stroke, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Stroke Strokes Kidney Disease 40

Circulation

NOVEMBER 11, 2024

Introduction:The treatment of heart failure (HF) with hydralazine-isosorbide dinitrate (H-ISDN) in African Americans (AA) with New York Heart Association (NYHA) III-IV who remain symptomatic despite optimal medical therapy is a class Ia indication.

Heart Failure 40

Heart Failure Cardiac Arrest Kidney Disease Atrial Fibrillation 40

DAIC

APRIL 9, 2024

Left untreated, tricuspid regurgitation can lead to atrial fibrillation , heart failure , kidney disease and even death. Current nonsurgical treatments include diuretics (medicines that help remove excess fluid and salt) and drugs aimed at easing symptoms. Rogers , professor of cardiovascular medicine.

Tricuspid 111

Tricuspid Heart Valves Bicuspid/Mitral Quality of Life 111

CardiacWire

OCTOBER 27, 2024

It’s well known that heart disease is the U.S.’s s top cause of death, and our rising CVD rates have been widely covered, but a look back on some of the biggest stories of 2024 suggests that cardiovascular disease is about to become a much bigger problem. trillion, representing 4.6%

AFIB 59

AFIB Hypertension Kidney Disease Heart Disease 59

European Journal of Heart Failure

DECEMBER 1, 2023

Abstract Background Extracellular matrix remodeling is one of the key pathways involved in heart failure (HF) progression. SGLT2 inhibitors may have a role in attenuating myocardial fibrosis. The impact of SGLT2 inhibitors on blood markers of collagen turnover in humans is not fully elucidated.

Heart Failure 40

Heart Failure Biomarkers Kidney Disease Atrial Fibrillation 40

DAIC

SEPTEMBER 11, 2024

million Americans have atrial fibrillation. Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Circulation: Cardiovascular Quality & Outcomes

DECEMBER 6, 2023

Background:Overall outcomes and the escalation rate for home hospital admissions for heart failure (HF) are not known. had chronic kidney disease, and 60.6% had atrial fibrillation. Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. were women, and 64.8% were White. Of the cohort, 29.2%

Heart Failure 40

Heart Failure Hospital Outcomes Inpatient 40

Journal of the American Heart Association

MARCH 27, 2025

Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovascular disease and smoking); (..)

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Stroke Journal

JANUARY 30, 2025

Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics. 2.39), P=0.99).

Outcomes 40

Outcomes Atrial Fibrillation Heart Failure Tachycardia 40

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Solomon, MD and Muthiah Vaduganathan, MD, MPH (USA) presented results showing that finerenone significantly reduced heart failure hospitalizations and cardiovascular death in patients with HFmrEF and HFpEF.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Cardiometabolic Health Congress

DECEMBER 7, 2023

The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrial fibrillation (AF). link] ACC/AHA Release Updated Atrial Fibrillation Guidelines for 2023. Sources: Joglar, J, Chung, M. J Am Coll Cardiol.

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Stroke 111

Dr. Smith's ECG Blog

APRIL 8, 2016

He also had a history of chronic kidney disease, stage III. Angio had shown some acute disease in the saphenous vein graft to the posterior descending artery off of the RCA. There is atrial fibrillation. Heart failure leading to death was related to all subclasses of PVC. mEq/L: The STE is resolved.

STEMI 52

STEMI Myocardial Infarction Cardiac Arrest Arrhythmia 52

Open Heart

JULY 6, 2023

Background Chronic kidney disease (CKD) and atrial fibrillation (AF) are increasing in prevalence globally and share common risk factors. Age, sex, diabetes, hypertension and heart failure were chosen as variables of interest. Methods PubMed, EMBASE and CINAHL were searched from inception to June 2022.

Kidney Disease 52

Kidney Disease Atrial Fibrillation Heart Failure Risk Factors 52

Open Heart

JANUARY 13, 2023

Objectives Accurate prediction of heart failure (HF) patients at high risk of atrial fibrillation (AF) represents a potentially valuable tool to inform shared decision making. No validated prediction model for AF in HF is currently available. The objective was to develop clinical prediction models for 1-year risk of AF.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Myocardial Infarction Kidney Disease 52

Open Heart

SEPTEMBER 14, 2022

Aims To describe the use of warfarin and direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) and chronic kidney disease (CKD), to evaluate changes in renal function over time and predictors of rapid decline, and to describe time in therapeutic range (TTR) and predictors of poor TTR among patients on warfarin.

Kidney Disease 52

Kidney Disease Atrial Fibrillation Heart Failure Diabetes 52

Circulation

NOVEMBER 11, 2024

It is highly recommended to screen for liver fibrosis in patients with Type 2 diabetes mellitus (T2DM) and elevated liver enzymes using the fibrosis-4 (FIB-4) score.However, this recommendation does not extend to patients with chronic heart failure (CHF) who do not have T2DM. 1.45), cardiovascular mortality (HR: 1.80, 95% CI: 1.49-2.17),

Heart Failure 40

Heart Failure Diabetes Myocardial Infarction Kidney Disease 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

In multivariate regression analysis, the factors independently associated with a greater risk of readmission within 90 days were hypercoagulation (1.359 [95%CI, 1.1274‐1.45]), opiod abuse and dependence (1.353 [95%CI, 1.238‐1.478]), chronic kidney disease (1.347 [95%CI, 1.316‐1.379]), liver disease (1.318 [95% CI, 1.26‐1.378]),

Risk Factors 40

Risk Factors Stroke Strokes Medicare 40